Two Sigma Advisers
ONC

Two Sigma Advisers’s BeOne Medicines Ltd ONC Stock Holding History

Two Sigma Advisers’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,575
Closed -$479K – 2287
2025
Q4 		$479K Buy
+1,575
New +$516K ﹤0.01% 1802
2025
Q2 		– Sell
-62,400
Closed -$17M – 2593
2025
Q1 		$17M Buy
+62,400
New +$14.6M 0.04% 373
2021
Q3 		– Sell
-700
Closed -$240K – 2718
2021
Q2 		$240K Buy
+700
New +$232K ﹤0.01% 2215

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Two Sigma Advisers's ONC Position: Q1 2026 in Review

Two Sigma Advisers sold out of BeOne Medicines Ltd (ONC) in Q1 2026, closing a stake of 1,575 shares — an estimated $479K sold.

Two Sigma Advisers first reported a position in ONC in Q2 2021 and held it in 3 quarters. The position peaked at $17M in Q1 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Two Sigma Advisers reported no remaining BeOne Medicines Ltd position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 1,575 BeOne Medicines Ltd shares in Q1 2026, an estimated $479K.
  • Two Sigma Advisers first reported a position in BeOne Medicines Ltd in Q2 2021 and held it in 3 quarters.
  • Two Sigma Advisers's BeOne Medicines Ltd position peaked at $17M in Q1 2025.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.